SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?


To: Joe Copia who wrote (527)10/28/1998 6:51:00 PM
From: Lane Hall-Witt  Read Replies (2) | Respond to of 1286
 
No kidding! They were obviously trying to get the price high enough to make the daytraders feel good about their profit and bail, then take the weak hands with them. I was amazed at how little selling I was noticing on the way down. (It might have been there, but I didn't watch carefully enough to see it.) I mean, many of us are in with 80-125 percent profit at bid=.60, and not too many of us were racing for the exits. I see more upside here, assuming that the good news we're expecting is really on its way.



To: Joe Copia who wrote (527)10/28/1998 8:01:00 PM
From: jhild  Respond to of 1286
 
You know Joe that 67&cent figure is an interesting number. If you take into account the stated assets from the last financial they have made public (notice I am careful not to say filed with the SEC), and you divide by the common outstanding on a fully diluted basis taking into account the conversion of the preferred 1.2 million giving a 15.5 million share denominator, it looks like it is just about 67&cent.

I have found all this talk about a $2.93 book value quite deceptive because of this preferred conversion.

The kicker of course is that we have yet to see any independent verification that the assets are really worth even this much to begin with.